Literature DB >> 2582439

Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma.

L G Gomella1, E R Sargent, T P Wade, P Anglard, W M Linehan, A Kasid.   

Abstract

Normal kidney and renal cell carcinoma tissues from ten patients were studied for mRNA and DNA for both transforming growth factors alpha and beta 1. Northern and Southern hybridizations were conducted on samples extracted from the solid tumor and surrounding normal tissues and two tumor-derived cell lines. Low levels of constitutive expression of TGF-alpha mRNA were detected in all normal kidney tissues; six of the ten patients, however, demonstrated an increased (2- to 8-fold) expression of TGF-alpha in the tumor versus normal kidney as determined by densitometry of RNA blots. All ten patients had elevated mRNA levels for TGF-beta 1 in the tumor (2.5-to 22-fold increase) relative to normal kidney. Two tumor-derived cell lines also expressed TGF-alpha and TGF-beta 1 mRNA. Southern blot hybridization of the DNA extracted from the normal tumor pairs revealed no gene amplification or gross rearrangement for either the TGF-alpha or TGF-beta 1 genes. These results demonstrate the expected constitutive expression of TGF-beta 1 by normal kidney; however, the constitutive expression of TGF-alpha by Northern blot analysis in normal adult human kidney is previously unreported. Enhanced expression of TGF-alpha and TGF-beta 1 mRNA in solid tumor may be related to the development of renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2582439

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Interleukin-6 and renal cell cancer: production, regulation, and growth effects.

Authors:  A S Koo; C Armstrong; B Bochner; T Shimabukuro; C L Tso; J B deKernion; A Belldegrum
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 2.  Growth factors and renal cancer: characterization and therapeutic implications.

Authors:  J H Mydlo
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

3.  TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103.

Authors:  S W Lin; M T Lee; F C Ke; P P Lee; C J Huang; M M Ip; L Chen; J J Hwang
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells.

Authors:  R G Uzzo; P Rayman; V Kolenko; P E Clark; M K Cathcart; T Bloom; A C Novick; R M Bukowski; T Hamilton; J H Finke
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

5.  Epidermal growth factor receptor gene expression and binding capacity in renal cell carcinoma, in relation to tumor stage, grade and DNA ploidy.

Authors:  B Ljungberg; M Gåfvels; J E Damber
Journal:  Urol Res       Date:  1994

6.  Biphasic regulation of ENaC by TGF-{alpha} and EGF in renal epithelial cells.

Authors:  Lian Liu; Billie Jeanne Duke; Bela Malik; Qiang Yue; Douglas C Eaton
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-18

7.  Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10.

Authors:  R S Yeung; K H Buetow; J R Testa; A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 8.  The role of fibroblasts in tumor behavior.

Authors:  M Grégoire; B Lieubeau
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

Review 9.  The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology.

Authors:  Fenghua Zeng; Amar B Singh; Raymond C Harris
Journal:  Exp Cell Res       Date:  2008-08-19       Impact factor: 3.905

10.  S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling.

Authors:  Ran Xie; Matthew P Schlumbrecht; Gregory L Shipley; Susu Xie; Roland L Bassett; Russell R Broaddus
Journal:  Lab Invest       Date:  2009-06-08       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.